• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEF 14A filed by FitLife Brands Inc.

    7/5/24 8:00:31 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email
    DEF 14A 1 ftlf20240702_def14a.htm FORM DEF 14A ftlf20240702_def14a.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a)

    of the Securities Exchange Act of 1934

     

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☒

    Definitive Proxy Statement

    ☐

    Definitive Additional Materials

    ☐

    Soliciting Material under §240.14a-12

     

    FITLIFE BRANDS, INC.

    (Name of Registrant as Specified In Its Charter)

     

     

     


    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

    ☐

    Fee paid previously with preliminary materials.

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a‑6(i)(1) and 0‑11.

     

     

     

     

     

    FITLIFE BRANDS, INC.

    5214 S. 136th Street

    Omaha, Nebraska 68137

    (402) 991-5618

     

    July 5, 2024

     

    Dear Stockholders of FitLife Brands, Inc.:

     

    You are cordially invited to attend the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of FitLife Brands, Inc. (the “Company”), which will be held at the offices of the Company located at 5214 S. 136th Street, Omaha, Nebraska, on August 13, 2024, at 9:00 a.m., local time.

     

    Details of the business to be conducted at the Annual Meeting are provided in the attached Notice of Annual Meeting of Stockholders and Proxy Statement. We have also provided a copy of our 2023 Annual Report on Form 10-K (“Annual Report”). We encourage you to read our Annual Report. It includes our audited financial statements and provides information about our business.

     

    Regardless of whether you plan to attend the Annual Meeting in person, please read the accompanying Proxy Statement and then vote by Internet, telephone or mail as promptly as possible. Please refer to the enclosed proxy card for instructions on submitting your vote. Voting promptly will save us additional expense in soliciting proxies and will ensure that your shares are represented at the Annual Meeting. If you decide to attend the Annual Meeting, you will be able to vote in person, even if you have previously submitted your proxy. Voting at the Annual Meeting will supersede any votes previously cast.

     

    Our Board of Directors has unanimously approved the proposals set forth in the Proxy Statement and we recommend that you vote in favor of each such proposal.

     

    We look forward to seeing you at the Annual Meeting.

     

     

    Sincerely,

       
     
    djudd.jpg
     

    Dayton Judd

    Chief Executive Officer and Chairman

     

     

    YOUR VOTE IS IMPORTANT

    All stockholders are cordially invited to attend the Annual Meeting in person. However, to ensure your representation at the Annual Meeting, you are urged to vote by Internet, telephone or mail as promptly as possible. Submitting your vote assures that a quorum will be present at the Annual Meeting and avoid the additional expense of duplicate proxy solicitations. Any stockholder attending the Annual Meeting may vote in person, even if he or she has returned a proxy.

     

     

     

     

    FITLIFE BRANDS, INC.

    5214 S. 136th Street

    Omaha, Nebraska 68137

    (402) 991-5618

     

    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

    To Be Held on August 13, 2024

     

     

    Dear Stockholders of FitLife Brands, Inc.:

     

    We are pleased to invite you to attend the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of FitLife Brands, Inc. (the “Company”), a Nevada corporation, which will be held at the offices of the Company located at 5214 S. 136th Street, Omaha, Nebraska, on August 13, 2024, at 9:00 a.m., local time, for the following purposes:

     

     

    1.

    To elect five directors to our Board of Directors, each to serve until our next Annual Meeting of Stockholders or until his respective successor is elected and qualified;

       

     

     

    2.

    Ratifying the appointment of Weinberg & Company, P.A. as our independent auditors for the fiscal year ending December 31, 2024; and

       

     

     

    3.

    Such other matters as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.

     

    These matters are more fully discussed in the attached Proxy Statement.

     

    The close of business on July 3, 2024 (the “Record Date”) has been fixed as the Record Date for the determination of stockholders entitled to notice of and to vote at the Annual Meeting or any adjournments or postponements thereof. Only holders of record of common stock at the close of business on the Record Date are entitled to notice of, and to vote at, the Annual Meeting. A complete list of these stockholders will be available for examination by any of our stockholders for purposes pertaining to the Annual Meeting at our corporate offices, 5214 S. 136th Street, Omaha, Nebraska 68137, during normal business hours for a period of ten days prior to the Annual Meeting, and at the time and place of the Annual Meeting.  

     

    Whether or not you expect to attend in person, we urge you to vote your shares as promptly as possible by Internet, telephone or mail so that your shares may be represented and voted at the Annual Meeting. If your shares are held in the name of a bank, broker or other fiduciary, please follow the instructions on the voting instruction card furnished by the record holder.

     

    Our Board of Directors unanimously recommends that you vote “FOR” Proposal Nos. 1 and 2, each of which are described in detail in the accompanying Proxy Statement. 

     

    IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING TO BE HELD ON AUGUST 13, 2024:

     

    THE ANNUAL REPORT AND PROXY STATEMENT ARE AVAILABLE ONLINE AT: www.colonialstock.com/FTLF2024.

     

     

    By Order of the Board of Directors,

       
      djudd.jpg

    Omaha, Nebraska

    Dayton Judd

    July 5, 2024

    Chief Executive Officer and Chairman

     

     

     

     

    FITLIFE BRANDS, INC.

    5214 S. 136th Street

    Omaha, Nebraska 68137

    (402) 991-5618

     

    PROXY STATEMENT

     

    The enclosed proxy is solicited on behalf of the Board of Directors of FitLife Brands, Inc., a Nevada corporation (the “Company”), for use at the 2024 Annual Meeting of Stockholders (“Annual Meeting”) to be held on August 13, 2024, at 9:00 a.m., local time, and at any adjournment or postponement thereof, at the offices of the Company located at 5214 S. 136th Street, Omaha, Nebraska.  

     

    These proxy solicitation materials were mailed on or about July 5, 2024, to all stockholders entitled to notice of, and to vote at, our Annual Meeting. The proxy materials are also available free of charge on the Internet at: www.colonialstock.com/FTLF2024.

     

    Voting

     

    The specific proposals to be considered and acted upon at our Annual Meeting are described in more detail in this Proxy Statement.  Stockholders of record at the close of business on July 3, 2024 (the “Record Date”) are entitled to notice of and to vote at the Annual Meeting. As of the close of business on the Record Date, the Company had 4,598,241 shares of common stock, $0.01 par value per share (“Common Stock”), issued and outstanding. Each holder of Common Stock is entitled to one vote for each share held as of the Record Date.

     

    Quorum

     

    In order for any business to be conducted at the Annual Meeting, the holders of more than 50% of the shares entitled to vote must be represented at the Annual Meeting, either in person or by properly executed proxy. If a quorum is not present at the scheduled time of the Annual Meeting, the Chairman (or other person presiding at the Annual Meeting) may adjourn the Annual Meeting until a quorum is present. The time and place of the adjourned Annual Meeting will be announced at the time the adjournment is taken, and no other notice will be given. An adjournment will have no effect on the business that may be conducted at the Annual Meeting.

     

    Required Vote for Approval

     

    Proposal No. 1: Election of Directors. For the five nominees who receive the greatest number of votes cast at the Annual Meeting by the shares present in person or by proxy and entitled to vote will be elected.

     

    Proposal No. 2: Ratification of Appointment of Auditors. To ratify the appointment of Weinberg & Company, P.A. as our independent auditors for the fiscal year ending December 31, 2024, the number of votes cast “FOR” must exceed the number of votes cast “AGAINST” this Proposal.

     

    Abstentions and Broker Non-Votes

     

    All votes will be tabulated by the inspector of election appointed for the Annual Meeting, who will separately tabulate affirmative and negative votes, abstentions and broker non-votes. An abstention is the voluntary act of not voting by a stockholder who is present at a meeting and entitled to vote. A broker “non-vote” occurs when a broker nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary power for that particular item and has not received instructions from the beneficial owner. If you hold your shares in “street name” through a broker or other nominee, your broker or nominee may not be permitted to exercise voting discretion with respect to some of the matters to be acted upon.  If you do not give your broker or nominee specific instructions regarding such matters, your proxy will be deemed a “broker non-vote.”

     

    Under Nevada law and our Bylaws, each matter (other than the election of directors) requires the affirmative vote of the majority of votes cast by stockholders present or represented by proxy (meaning the number of shares voted “FOR” a proposal must exceed the number of shares “AGAINST” such proposal). Abstentions and broker non-votes are not considered votes cast and, therefore, do not have any effect on the outcome of these matters.

     

     

     

     

    Proxies

     

    If your proxy is properly returned to the Company, the shares represented thereby will be voted at the Annual Meeting in accordance with the instructions specified thereon. If you return your proxy without specifying how the shares represented thereby are to be voted, the proxy will be voted (i) FOR the election of five directors nominated by our Board, (ii) FOR ratification of the appointment of Weinberg & Company, P.A. as our independent auditors for fiscal year 2024, and (iii) at the discretion of the proxy holders on any other matter that may properly come before the Annual Meeting or any adjournment or postponement thereof.

     

    You may revoke or change your proxy at any time before the Annual Meeting by filing with our Corporate Secretary at our principal executive offices at 5214 S. 136th Street, Omaha, Nebraska 68137, a notice of revocation or another signed proxy with a later date. You may also revoke your proxy by attending the Annual Meeting and voting in person.  Attendance at the Annual Meeting alone will not revoke your proxy.  If you are a stockholder whose shares are not registered in your own name, you will need additional documentation from your broker or record holder to vote personally at the Annual Meeting.

     

    Solicitation

     

    We will bear the entire cost of solicitation, including the preparation, assembly, printing and mailing of this Proxy Statement, the Company’s 2023 Annual Report on Form 10-K (the “Annual Report”), the proxy card and any additional solicitation materials furnished to the stockholders. Copies of any solicitation materials will be furnished to brokerage houses, fiduciaries and custodians holding shares in their names that are beneficially owned by others so that they may forward this solicitation material to such beneficial owners. In addition, we may reimburse such persons for their costs in forwarding the solicitation materials to such beneficial owners. The original solicitation of proxies may be supplemented by a solicitation by telephone, e-mail or other means by our directors, officers or employees. No additional compensation will be paid to these individuals for any such services. Except as described above, we do not presently intend to solicit proxies other than by email, telephone and mail.

     

     

     

     

    MATTERS TO BE CONSIDERED AT ANNUAL MEETING

     

    PROPOSAL NO. 1

     

    ELECTION OF DIRECTORS

     

    General

     

    Our Bylaws provide that the Board of Directors shall consist of not less than one, nor more than nine directors, and that upon any change in the number of directors, any newly created directorships or eliminated directorships shall be apportioned by the remaining members of the Board of Directors or by stockholders. The Company’s Board of Directors currently consists of five directors. Mr. Lewis Jaffe has notified the Company that he will not stand for re-election at the Annual Meeting and will retire from the Board at that time. Mr. Jaffe has been a director of the Company since 2010 and will continue as a director until his term ends immediately prior to the Annual Meeting.

     

    Five directors are nominated for election at the Annual Meeting. Each nominee has confirmed that he will be able and willing to serve as a director if elected. If any of the nominees becomes unable or unwilling to serve, your proxy will be voted for the election of a substitute nominee recommended by the current Board of Directors. Upon recommendation of the Board of Directors, the Board of Directors has nominated for election as directors at our Annual Meeting Messrs. Dayton Judd, Grant Dawson, Matt Lingenbrink, Todd Ordal and Seth Yakatan.

     

    Required Vote and Recommendation

     

    The election of directors shall be elected by a plurality of the votes cast (meaning the five nominees receiving the highest number of shares voted “FOR” their election will be elected). “WITHHOLD” votes and broker non-votes are not considered votes cast for the foregoing purpose and will have no effect on the election of the nominees. Unless otherwise instructed or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” the election of the nominees.

     

    The Board of Directors recommends that the stockholders vote “FOR” the election of Messrs. Judd, Dawson, Yakatan, Ordal and Lingenbrink.

     

    The following sections set forth certain information regarding the nominees for election as directors of the Company. There are no family relationships between any of the directors and the Company’s executive officers.

     

    Name

     

    Age

     

    Title

    Dayton Judd

     

    52

     

    Chief Executive Officer and Chairman

    Grant Dawson

     

    55

     

    Director

    Matt Lingenbrink

     

    42

     

    Director Nominee

    Todd Ordal

     

    67

     

    Director

    Seth Yakatan

     

    53

     

    Director

     

    Each of the Company’s executive officers and directors will hold office until their successors are duly elected and qualified.  The background and principal occupations of each director nominee are as follows:

     

    Dayton Judd has served as a director of the Company since June 2017, is currently the Chairman of the Company’s Board of Directors and began serving as the Company’s Chief Executive Officer on February 18, 2018. Mr. Judd is the founder and Managing Partner of Sudbury Capital Management (“Sudbury”). Prior to founding Sudbury, Mr. Judd worked from 2007 through 2011 as a Portfolio Manager at Q Investments, a multi-billion dollar hedge fund in Fort Worth, Texas. Prior to Q Investments, he worked with McKinsey & Company from 1996 through 1998, and again from 2000 through 2007. He graduated from Brigham Young University in 1995 with a Bachelors Degree, summa cum laude, and a Masters Degree, both in accounting. He also earned an M.B.A. with high distinction from Harvard Business School in 2000, where he was a Baker Scholar. Mr. Judd is a Certified Public Accountant. He currently serves on the Board of Directors of LifeVantage Corp (Nasdaq: LFVN) and Optex Systems Holdings Inc. (Nasdaq: OPXS).

     

     

     

     

    The Company’s Nominating and Corporate Governance Committee believes that Mr. Judd’s significant experience in investing in microcap companies, together with his substantial ownership position in the Company’s Common Stock, assists the Board of Directors in the management of the Company and setting goals and objectives to build stockholder value.

     

    Grant Dawson has served as a director of the Company since November 2013 and is currently a Portfolio Manager of Fixed Income Investments for Polar Asset Management Partners (“Polar”), where he has worked since 2014. Mr. Dawson brings more than 20 years of experience in finance and has significant board-level experience in corporate governance for public companies. Prior to Polar, he was Managing Director of Fixed Income Investments for Manulife Asset Management, a subsidiary of Manulife Financial Corporation and Vice President and Lead Analyst responsible for corporate debt ratings with Dominion Bond Rating Agency. Prior to such time, Mr. Dawson held various senior management positions in credit management and corporate finance with Nortel and in equity research with Dain Rauscher Ltd. Mr. Dawson earned an M.B.A. from the SMU Cox School of Business, a B.Comm in Finance from the University of Windsor, and holds the Chartered Financial Analyst designation. Additionally, Mr. Dawson is a member of the Institute of Corporate Directors and holds the ICD.D designation.

     

    The Company’s Nominating and Corporate Governance Committee believes that Mr. Dawson’s extensive expertise and knowledge regarding corporate finance and investment banking matters, as well as corporate governance, provides the Company with valuable insight. 

     

    Matt Lingenbrink, director nominee, currently leads the marketing organization of Interstate Batteries as Vice President, Marketing and E-commerce since April 2024. Prior to his time at Interstate Batteries, he held various roles leading corporate strategy, business development, and route-to-market at Keurig Dr Pepper Inc., and its predecessor Dr Pepper Snapple Group, from August 2017 to April 2024. Prior to that, Mr. Lingenbrink worked with Bain & Company from September 2007 to August 2017, consulting with large clients across the consumer packaged goods industry and other industries on growth strategy, corporate diligence, and post-merger integration. Mr. Lingenbrink received his Bachelor’s Degree and a Master’s Degree in Accounting from Brigham Young University, and earned an M.B.A. from Harvard Business School.

     

    The Company’s Nominating and Corporate Governance Committee believes that Mr. Lingenbrink’s broad experience with consumer products strategy, marketing, and distribution will provide management and the Board of Directors with valuable perspectives relating to enhancing the value of the Company’s brands. 

     

    Todd Ordal has served a director of the Company since September 2015, and is the President and founder of Applied Strategy, LLC, a private consulting company founded in 2003 that provides consulting and coaching services to chief executive officers and other executives around the word. Prior to joining the Company’s Board of Directors, Mr. Ordal served as a director for iSatori, Inc. from April 2012 until the completion of the Company’s acquisition of iSatori. Before founding Applied Strategy, LLC, Mr. Ordal served as Chief Executive Officer of Dore Achievement Centers from December 2002 until November 2004, and President and Chief Executive Officer of Classic Sports Companies from January 2001 until December 2002. Prior to Classic Sport Companies, Mr. Ordal served as a Division President for Kinko’s Service Corporation, where he had accountability for $500 million in revenue, 300 stores and 7,000 people, and as a member of the Board of Directors for Kinko’s from July 1992 until July 1997. He has also served on several non-profit boards and boards of advisors. Mr. Ordal received his Bachelors Degree in psychology from Morehead State University and his M.B.A. from Regis University.

     

    The Company’s Nominating and Corporate Governance Committee believes that Mr. Ordal’s considerable experience with growing successful businesses, as well as his extensive knowledge and understanding of marketing and finance matters, provides the Board of Directors with valuable guidance and insight.

     

    Seth Yakatan has served a director of the Company since September 2015, and as a Partner of Katan Associates, Inc., a corporate strategy and finance advisory group, since April 2001. Prior to joining the Company’s Board of Directors, Mr. Yakatan served as a director for iSatori, Inc. from September 2014 until the completion of the Company’s acquisition of iSatori. Prior to founding Katan Associates, Inc. in 2001, Mr. Yakatan worked in merchant banking at the Union Bank of California, N.A. in the Specialized Lending Media and Telecommunications Group, and as a venture capital analyst with Ventana Growth Funds and Sureste Venture Management. Mr. Yakatan holds an M.B.A. in Finance from the University of California, Irvine, and a Bachelor of Arts in History and Public Affairs from the University of Denver.

     

     

     

     

    The Company’s Nominating and Corporate Governance Committee believes that Mr. Yakatan’s 25 years of experience as a life sciences business development and corporate finance professional, including actively supporting small cap and major companies in achieving corporate, financing, and asset monetization objectives, provides the Board of Directors with valuable guidance and expertise based on his extensive knowledge and understanding of banking matters.

     

    There have been no events under any bankruptcy act, no criminal proceedings and no judgments or injunctions material to the evaluation of the ability and integrity of any of the Company’s director nominees during the past ten years.

     

    CORPORATE GOVERNANCE, BOARD COMPOSITION AND BOARD COMMITTEES

     

    Term of Office

     

    Pursuant to our Bylaws, each member of the Board serves from the date they are duly elected and qualified, until the Company’s following annual meeting of stockholders or until their death, resignation or removal from office.

     

    Board Member Independence

     

    The Board believes that a majority of its members are independent directors. The Board has determined that, with the exception of Mr. Judd who also serves as the Company’s Chief Executive Officer, all directors are independent as defined by the rules and regulations of the Nasdaq Capital Market.

     

    Board Structure

     

    The Board does not have a policy regarding the separation of the roles of the Chief Executive Officer and Chair of the Board, as the Board believes it is in the best interest of the Company and its stockholders to make that determination based on the position and direction of the Company and the membership of the Board, from time to time. Currently, Mr. Judd serves as both the Chief Executive Officer and as Chair of the Board. At this time, the Board believes that these combined roles are beneficial to both the daily operations of the Company and the strategic perspective of the Board.

     

    Board Risk Oversight

     

    Our Board administers its oversight function through both regular and special meetings and by frequent telephonic updates with our senior management. A key element of these reviews is gathering and assessing information relating to risks of our business. All businesses are exposed to risks, including unanticipated or undesired events or outcomes that could impact an enterprise’s strategic objectives, organizational performance and stockholder value. A fundamental part of risk management is not only understanding such risks that are specific to our business, but also understanding what steps management is taking to manage those risks and what level of risk is appropriate. In setting our business strategy, our Board assesses the various risks being mitigated by management and determines what constitutes an appropriate level of risk.

     

    Although our Board has the ultimate oversight responsibility for our risk management process, various committees of our Board also have responsibility for risk management. In particular, the Audit Committee focuses on financial risk, including internal controls, and the assessments of risks reflected in audit reports. Legal and regulatory compliance risks are also reviewed by our Audit Committee. Risks related to our compensation programs are reviewed by the Compensation Committee. Our Board is advised by the committees of significant risks and management’s response via periodic updates.

     

     

     

     

    Board Meetings

     

    The Board held five meetings during the year ended December 31, 2023, supplemented by numerous additional discussions by and among a majority of the Board, and numerous actions effectuated by unanimous written consent in lieu of a formal motion and vote during an official meeting. In 2023, incumbent directors attended 100% of the aggregate number of meetings of the Board. The Board also holds independent executive sessions without members of management on an as-needed basis.

     

    Board Committees and Charters

     

    The Board has three standing committees which consists of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. The Board appoints the members and committee chair of each committee (based upon the recommendation of the Nominating and Corporate Governance Committee). Each independent director also serves as a member of the standing committees of the Board. Copies of each committee charter are available upon request to the Company’s Corporate Secretary at 5214 S. 136th Street, Omaha, Nebraska 68137.

     

    Audit Committee

     

    Members:

     

    Grant Dawson (Chair)

    Lewis Jaffe

    Todd Ordal

    Seth Yakatan

         

    Number of Meetings Held:

     

    The Audit Committee held four meetings during 2023 and handled other matters via unanimous written consent or in Board meetings. 

         

    Functions:

     

    The Audit Committee assists the Board in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions by approving the services performed by our independent accountants and reviewing their reports regarding our accounting practices and systems of internal accounting controls. The Audit Committee also oversees the audit efforts of our independent accountants and takes those actions as it deems necessary to satisfy it that the accountants are independent of management.

         

    Independence

      The members of the Audit Committee each meet the independence standards established by the Nasdaq Capital Market and by the Securities and Exchange Commission (the “SEC”) for audit committees. In addition, the Board has determined that Messrs. Dawson, Jaffe and Ordal each satisfy the definition of an “audit committee financial expert” under SEC rules and regulations. These designations do not impose any duties, obligations or liabilities on Messrs. Dawson, Jaffe and Ordal that are greater than those generally imposed on them as members of the Audit Committee and the Board, and their designations as audit committee financial experts does not affect the duties, obligations or liability of any other member of the Audit Committee or the Board.

     

    Compensation Committee

     

    Members:

     

    Grant Dawson (Chair)

    Lewis Jaffe

    Todd Ordal

    Seth Yakatan

         

    Number of Meetings Held:

     

    The Compensation Committee held one meeting during 2023 and handled other matters via unanimous written consent or in board meetings. 

         

    Functions:

     

    The Compensation Committee determines our general compensation policies and the compensation provided to our directors and officers. The Compensation Committee also reviews and determines bonuses for our officers and other employees. In addition, the Compensation Committee reviews and determines equity-based compensation for our directors, officers, employees and consultants and administers our stock option plans and employee stock purchase plan.

     

     

     

     

    Independence

     

    We believe that the composition of our Compensation Committee meets the criteria for independence under, and the functioning of our Compensation Committee complies with, the applicable requirements of the Sarbanes-Oxley Act of 2002 and current SEC rules and regulations.

     

    Nominating and Corporate Governance Committee

     

    Members:

     

    Lewis Jaffe (Chair)

       

    Grant Dawson

    Todd Ordal

       

    Seth Yakatan

         

    Number of Meetings Held:

     

    The Nominating and Corporate Governance Committee held no meetings during 2023, electing instead to address Committee matters by action taken by the full Board.

         

    Functions:

     

    The Nominating and Corporate Governance Committee is responsible for making recommendations to the Board of Directors regarding director candidates and the size and composition of the Board and its committees. In addition, the Nominating and Corporate Governance Committee is responsible for overseeing our corporate governance guidelines and reporting and making recommendations to the Board concerning corporate governance matters.

         

    Independence

     

    We believe that the composition of our Nominating and Corporate Governance Committee meets the criteria for independence under, and the functioning of our Nominating and Corporate Governance Committee complies with, the applicable requirements of the Sarbanes-Oxley Act of 2002 and current SEC rules and regulations.

     

    Board Diversity

     

    The table below provides certain highlights of the composition of our Board members and nominees as of July 1, 2024. Each of the categories listed in the tables below has the meaning as it is used in Nasdaq Listing Rule 5605(f).

     

    Board Diversity Matrix

    (As of July 1, 2024)

    Total Number of Directors

    5

    Gender Identity

    Female

    Male

    Non-Binary

    Did Not

    Disclose

    Gender

    Directors

     

    3

    —

    2

    Demographic Background

           

    African American or Black

    —

    —

    —

    —

    Alaskan Native or Native American

    —

    —

    —

    —

    Asian

    —

     

    —

    —

    Hispanic or Latinx

    —

    —

    —

    —

    Native Hawaiian or Pacific Islander

    —

    —

    —

    —

    White

     

    3

    —

    —

    Two or More Races or Ethnicities

    —

    —

    —

    —

    LGBTQ+

    —

    Did Not Disclose Demographic Background

    2

     

     

     

     

    Stockholder Communications with the Board of Directors

     

    Our Board of Directors provides stockholders with the ability to send communications to the Board of Directors, and stockholders may do so at their convenience. In particular, stockholders may send their communications to:

     

    Board of Directors

    c/o Corporate Secretary

    FitLife Brands, Inc.

    5214 S. 136th Street

    Omaha, Nebraska 68137

     

    All communications received by the Corporate Secretary are relayed to the Board of Directors of the Company. Members of the Board of Directors are not required to attend our Annual Meetings of Stockholders.

     

     

     

     

    PROPOSAL NO. 2

     

    RATIFICATION OF THE APPOINTMENT OF

    WEINBERG & COMPANY, P.A. TO SERVE AS OUR

    REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR

     

    The Board of Directors has appointed Weinberg & Company, P.A. (“Weinberg”) as our independent registered public accounting firm for the current fiscal year and hereby recommends that the stockholders ratify such appointment.

     

    The Board of Directors may terminate the appointment of Weinberg as the Company’s independent registered public accounting firm without the approval of the stockholders whenever the Board of Directors deems such termination necessary or appropriate.

     

    Representatives of Weinberg will be present at the Annual Meeting, or available by telephone, and will have an opportunity to make a statement if they so desire and to respond to appropriate questions from stockholders. 

     

    Principal Accountant Fees and Services

     

    On October 6, 2022, the Company retained Weinberg as its independent registered public accounting firm for the fiscal year ended December 31, 2022.

     

    The following table sets forth the aggregate fees billed by Weinberg with respect to audit and non-audit services for the Company during the fiscal years ended December 31, 2023 and 2022:

     

       

    Year ended

    December 31,

     
       

    2023

       

    2022

     

    Audit fees

      $ 243,000     $ 148,000  

    Audit-related fees

        6,000       4,000  

    Tax fees

        -       -  

    All other fees

        34,000       -  

    Total

      $ 283,000     $ 152,000  

     

    As defined by the SEC, (i) “audit fees” are fees for professional services rendered by our principal accountant for the audit of our annual financial statements and review of financial statements included in our Form 10-K, or for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years; (ii) “audit-related fees” are fees for assurance and related services by our principal accountant that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “audit fees”; (iii) “tax fees” are fees for professional services rendered by an external consultant for tax compliance, tax advice, and tax planning (these services were performed by our principal accountant for the year ended December 31, 2021); and (iv) “all other fees” are fees for products and services provided by our principal accountant, other than the services reported under “audit fees”, “audit-related fees”, and “tax fees”.

     

    Audit Fees

     

    For the fiscal year ended December 31, 2023 and 2022, audit fees were approximately $243,000 and $148,000 respectively.

     

    Tax Fees

     

    For the fiscal year ended December 31, 2023 and 2022, the Company did not retain Weinberg for any tax services.

     

     

     

     

    All Other Fees

     

    During the fiscal years ended December 31, 2023 and 2022, all other fees for other services were $34,000 and $0, respectively.

     

    Audit Committee Pre-Approval Policies and Procedures

     

    Under the SEC’s rules, the Audit Committee is required to pre-approve the audit and non-audit services performed by the independent registered public accounting firm in order to ensure that they do not impair the auditors’ independence. The Commission’s rules specify the types of non-audit services that an independent auditor may not provide to its audit client and establish the Audit Committee’s responsibility for administration of the engagement of the independent registered public accounting firm.

     

    Consistent with the SEC’s rules, the Audit Committee Charter requires that the Audit Committee review and pre-approve all audit services and permitted non-audit services provided by the independent registered public accounting firm to us or any of our subsidiaries. The Audit Committee may delegate pre-approval authority to a member of the Audit Committee and if it does, the decisions of that member must be presented to the full Audit Committee at its next scheduled meeting. Accordingly, 100% of audit services and non-audit services described in this proposal were pre-approved by the Audit Committee.

     

    There were no hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

     

    Required Vote and Recommendation

     

    Ratification of the selection of Weinberg & Company, P.A. as the Company’s independent auditors for the fiscal year ending December 31, 2024 requires the affirmative vote of a majority of votes cast, either present or represented by proxy (meaning the number of shares voted “FOR” this proposal must exceed the number of shares voted “AGAINST” this proposal). Abstentions and broker non-votes are not considered votes cast for the foregoing purpose and will have no effect on the vote for this proposal. Unless otherwise instructed on the proxy or unless authority to vote is withheld, shares represented by executed proxies will be voted “FOR” the ratification of Weinberg & Company, P.A. as the Company’s independent auditors for the fiscal year ending December 31, 2024.

     

    The Board of Directors recommends that stockholders vote “FOR” the ratification of the selection of Weinberg & Company, P.A. as the Company’s independent auditors for the fiscal year ending December 31, 2024.

     

     

     

     

    EXECUTIVE OFFICERS

     

    The following table sets forth information regarding the executive officers of the Company:

     

    Name

     

    Age

     

    Title

    Dayton Judd

     

    52

     

    Chief Executive Officer

    Jakob York

     

    47

     

    Chief Financial Officer

    Patrick Ryan

     

    45

     

    Chief Retail Officer

    Jenna Sinnett

     

    45

     

    Chief Operating Officer

     

    The Chief Executive Officer and other officers of the Company hold their respective offices at the discretion of the Board.  

     

    Dayton Judd. The background and principal occupations of Mr. Judd is set forth above in Proposal No. 1.

     

    Jakob York has served as the Company’s Chief Financial Officer since he joined the Company in August 2022.  Prior to joining FitLife, he served as Controller for Greenidge Generation Holdings (“Greenidge”, NASDAQ: GREE).  Prior to Greenidge, Mr. York worked in various controller and financial reporting capacities, primarily at Allied Motion Technologies (NASDAQ: AMOT).  Prior to joining Allied Motion, he worked at Pricewaterhouse Coopers as an auditor from 2002 to 2007.  He graduated from Brigham Young University in 2002 with a Bachelors Degree and a Masters Degree in Accounting.  Mr. York is a Certified Public Accountant.

     

    Patrick Ryan has served as the Company’s Chief Retail Officer since his appointment in June 2016. He brings over 23 years of experience in the retail and wholesale business both domestically and internationally. Since February 2009, Mr. Ryan served as the Company’s Vice President of Sales during which time he oversaw multiple retail and wholesale branches and worked collaboratively with key members of management to drive strategic initiatives in sales, employee training and the overall growth of the Company. Prior to that, he served in various sales positions of increasing responsibility since joining the Company in 2004. Mr. Ryan received his Bachelor of Science Degree in Public Relations from Kansas State University.

     

    Jenna Sinnett has served as the Company’s Chief Operating Officer since her appointment in October 2015.  She brings over 18 years of operations experience in the wholesale business, managing domestic inventories, regulatory compliance, and product management.  In 2012, Ms. Sinnett was appointed Vice President of Supply Chain where she controlled all matters tied to procurement, including inventory management, logistics, and vendor relations. Over the course of her tenure, she has held senior positions in Project Management as well.  Ms. Sinnett received both her Bachelor of Science Degree and Master of Science Degree in Exercise Science from the University of Nebraska Omaha.

     

    There have been no events under any bankruptcy act, no criminal proceedings and no judgments or injunctions material to the evaluation of the ability and integrity of any of the Company’s executive officers during the past ten years.

     

     

     

     

    EXECUTIVE COMPENSATION

     

    Summary Compensation Table

     

    The following table sets forth information concerning the compensation paid to the Company’s Chief Executive Officer, and the Company’s two most highly compensated executive officers other than its Chief Executive Officer, who were serving as executive officers as of December 31, 2023 and whose annual compensation exceeded $100,000 during such year (collectively the “Named Executive Officers”).

     

    Name and principal position

     

    Year

       

    Salary

       

    Bonus

       

    Stock

    awards

       

    Warrants/
    option
    awards (1)

       

    All other

    compensation (2)

       

    Total

     
                                                             

    Dayton Judd

     

    2023

       

    $

    372,000

       

    $

    160,000

       

    $

    -

       

    $

    -

       

    $

    -

       

    $

    532,000

     

    Chief Executive Officer and Chair of the Board

     

    2022

       

    $

    340,462

       

    $

    135,000

       

    $

    -

       

    $

    -

       

    $

    -

       

    $

    475,462

     
                                                             

    Patrick Ryan

     

    2023

       

    $

    148,077

       

    $

    5,000

       

    $

    -

       

    $

    -

       

    $

    151,669

       

    $

    304,746

     

    Chief Retail Officer

     

    2022

       

    $

    138,077

       

    $

    -

       

    $

    -

       

    $

    -

       

    $

    186,045

       

    $

    324,122

     
                                                             

    Jakob York

     

    2023

       

    $

    204,616

       

    $

    40,000

       

    $

    -

       

    $

    16,060

       

    $

    -

       

    $

    260,676

     

    Chief Financial Officer

     

    2022 (3)

       

    $

    69,230

       

    $

    -

       

    $

    -

       

    $

    89,700

       

    $

    -

       

    $

    158,930

     

     

    (1)

    The amounts in this column represent the grant date fair value of stock option awards computed in accordance with FASB guidance, excluding the effect of estimated forfeitures under which the Named Executive Officer has the right to purchase, subject to vesting, shares of the Company’s Common Stock.

     

     

    (2)

    Amounts reflect commissions paid to the Named Executive Officer.

     

     

    (3)

    Jakob York began serving as CFO on August 15, 2022.

     

    Employment Arrangements

     

    Dayton Judd. Dayton Judd currently serves as the Company’s Chief Executive Officer. Effective August 28, 2023, the Board approved an increase of Mr. Judd’s salary from $364,000 to $390,000. Effective August 29, 2022, the Board approved an increase of Mr. Judd’s annual base salary from $330,000 to $364,000. Mr. Judd serves as an at-will employee without a formal employment agreement.

     

    Patrick Ryan. Under the terms of an Employment Agreement dated June 13, 2019, Patrick Ryan served in the capacity of Chief Retail Officer until the termination of the agreement on June 7, 2022. Subsequent to June 7, 2022, Mr. Ryan serves in the same capacity as an at-will employee without a formal employment agreement. In addition to a base salary, Mr. Ryan is paid a commission of 2.5% of the adjusted gross profit from the sale of certain of the Company’s products to the GNC franchise community. Effective August 29, 2022, the Board approved an increase of Mr. Ryan’s base salary from $135,000 to $145,000. Effective August 28, 2023, the Board approved an increase of Mr. Ryan’s base salary from $145,000 to $155,000.

     

    Jakob York. Jakob York joined the Company as Chief Financial Officer on August 15, 2022 with an annual base salary of $200,000. Upon joining the Company, Mr. York also received options to acquire 10,000 shares with an exercise price of $15.65. One-fourth of the options vested immediately, with the remainder vesting in three equal annual installments thereafter. Effective August 28, 2023, the Board approved an increase of Mr. York’s salary from $200,000 to $215,000 and granted Mr. York additional options to acquire 2,000 shares of Common Stock at an exercise price of $18.15. One-fourth of the options vested immediately, with the remainder vesting in three equal annual installments thereafter.

     

     

     

     

    Outstanding Equity Awards at Fiscal Year-End

     

    The following table sets forth information regarding unexercised options and stock that had not vested and equity incentive awards held by each of the Named Executive Officers outstanding as of December 31, 2023:

     

     

    Grant

    date

     

    Number of

    securities

    underlying

    unexercised

    options

    exercisable

       

    Number of

    securities

    underlying

    unexercised

    options

    unexercisable

       

    Equity
    incentive

    plan
    awards:

    Number of

    underlying

    unexercised

    unearned
    options

       

    Option

    exercise

    price

     

    Option

    expiration

    date

                                         

    Dayton Judd

    7/31/2018

       

    221,400

         

    -

         

    -

       

    $

    0.70

     

    7/31/2028

    Chief Executive Officer and Chairman

    2/5/2021

       

    72,000

         

    -

         

    -

       

    $

    5.24

     

    2/5/2026

    2/5/2021

       

    56,000

         

    -

         

    -

       

    $

    4.76

     

    2/5/2031

    Jakob York

    8/15/2022

       

    5,000

    (1)

       

    5,000

         

    -

       

    $

    15.65

     

    8/15/2027

    Chief Financial Officer

    8/15/2023

       

    500

    (2)

       

    1,500

         

    -

       

    $

    18.15

     

    8/15/2028

     

    (1)

    One-fourth of the stock options vested on the grant date of August 15, 2022, with the remainder vesting in three equal annual installments thereafter, becoming fully vested on August 15, 2025.

       

    (2)

    One-fourth of the stock options vested on the grant date of August 15, 2023, with the remainder vesting in three equal annual installments thereafter, becoming fully vested on August 15, 2026.

     

    Description of Equity Compensation Plan

     

    The 2019 Omnibus Incentive Plan (the “2019 Plan”) was adopted by the Board on July 3, 2019, as approved by a majority of the Company’s stockholders at the annual meeting of stockholders on August 16, 2019. The 2019 Plan reserves for issuance 400,000 shares of the Company’s Common Stock as one of four types of equity incentive awards: (i) stock options, (ii) stock appreciation rights, (iii) restricted stock, and (iv) stock units. The 2019 Plan permits the qualification of awards under the plan as “performance-based compensation” within the meaning of Section 162(m) of the Internal Revenue Code. Upon becoming effective, the Plan replaced, and no further awards were made under the Company’s 2010 Incentive Plan.

     

    Securities Authorized for Issuance Under Equity Compensation Plans

     

    The following table provides information as of December 31, 2023, with respect to the shares of Common Stock that may be issued upon the exercise of options and other rights under our existing equity compensation plans and arrangements. The information includes the number of shares covered by and the weighted average exercise price of outstanding options and other rights and the number of shares remaining available for future grants, excluding the shares to be issued upon exercise of outstanding options and other rights.

     

       

    Number of

    Securities to be
    issued upon
    exercise of
    outstanding
    options,
    warrants and
    rights

       

    Weighted-

    average

    exercise

    price of

    outstanding

    options,
    warrants

    and rights

       

    Number of

    securities

    remaining

    available

    for future
    issuance

    under equity

    compensation

    plans

    (excluding

    securities

    reflected in

    first column)

     

    Equity compensation plans approved by security holders:

       

    484,428

       

    $

    6.82

         

    145,000

     

     

    Compensation Committee Interlocks and Insider Participation

     

    No executive officers of the Company serve on the Compensation Committee (or in a like capacity) for the Company or any other entity. 

     

     

     

     

    PAY VERSUS PERFORMANCE

     

    The following table presents certain information regarding compensation paid to the Company’s Principal Executive Officer (“PEO”) and other Named Executive Officers (“Other NEOs” or “Non-PEOs”), and certain measures of financial performance, for the years ended December 31, 2023, 2022 and 2021. The amounts shown below are calculated in accordance with Item 402(v) of Regulation S-K. The Compensation Committee believes that 2023 compensation decisions for the PEO and Non-PEOs are reflective of the firm’s overall operating, strategic, financial and stock price performance and thus aligned with shareholders.

     

    Pay Versus Performance Table

     

    Year

     

    Summary

    Compensation

    Table

    Total for

    PEO (1)

       

    Compensation

    Actually

    Paid to

    PEO (1)

       

    Average

    Summary

    Compensation

    Total for

    Non-PEO Named

    Executive

    Officers (2)

       

    Value of

    Initial

    $100

    Investment

    based on Total

    Shareholder

    Return (3)

       

    Net Income

    ($)

     
                                             

    2023

     

    $

    532,000

       

    $

    637,120

       

    $

    282,711

       

    $

    354

       

    $

    5,296,000

     

    2022

     

    $

    475,462

       

    $

    411,022

       

    $

    241,526

       

    $

    295

       

    $

    4,429,000

     
    2021   $ 1,277,503     $ 2,941,259     $ 269,339     $ 196     $ 5,410,000  

     

    (1)

    Dayton Judd served as the Company’s PEO during the fiscal years presented. The following amounts were added and deducted from the Summary Compensation Table (“SCT”) amount to determine the compensation actually paid to the PEO in accordance with SEC regulations:

     

    Adjustments to Determine Compensation “Actually Paid”

     

    2023

       

    2022

       

    2021

     

    Deduction for Amount Reported under the “Stock Awards” column in the SCT

      $ -     $ -     $ (666,344 )

    Deduction for Amount Reported under the “Option Awards” column in the SCT

        -       -       (184,620 )

    Increase for the Fair Value of Awards Granted during year that remain unvested as of year-end

        -       -       680,400  

    Increase for the Fair Value of Awards Granted during year that remain vested as of year-end

        -       -       1,834,320  

    Increase/deduction for Change in Fair Value from prior year-end to current year-end of Awards Granted prior to year-end that were outstanding and unvested as of year-end

        86,980       (36,720 )     -  

    Increase/deduction for Change in Fair Value from prior year-end to Vesting Date of Awards Granted prior to year-end that vested during year

        18,140       (27,720 )     -  

    Total Adjustments

      $ 105,120     $ (64,440 )   $ 1,663,756  

     

    (2)

    For the year ended December 31, 2023, Patrick Ryan and Jakob York were our Other NEOs. For the years ended December 31, 2022 and 2021, Patrick Ryan and Jenna Sinnett were our Other NEOs. No adjustments were required for our Other NEOs as neither of them had components of their compensation that would require adjustments.

     

    (3)

    Represents the cumulative shareholder return of a fixed investment of $100 made at the closing price of the Company’s Common Stock at December 31, 2020 for the measurement period beginning on such date and continuing through and including the end of the applicable fiscal year reflected in the table.

     

    Analysis of the Information Presented in the Pay Versus Performance Table 

     

    We generally seek to incentivize long-term performance, and therefore do not specifically align our performance measures with “compensation actually paid” ​(as computed in accordance with Item 402(v) of Regulation S-K) for a particular year. In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table.

     

     

     

     

    PEO

     

    From 2022 to 2023, compensation actually paid to the PEO increased by $226,098 or 55%. Over the same period, the Company’s Total Shareholder Return increased by 19%. Key factors that drove the increase in pay during this period were an increase in the share price affecting the value of previously issued options.

     

    Other NEOs         

     

    From 2022 to 2023, compensation paid to the other NEOs increased by $41,185 or 17%. Over the same period, the Company’s Total Shareholder Return increased by 19%. Key factors that drove the increase in pay during this period were higher cash compensation to the Other NEOs.

     

    Compensation Actually Paid and Net Income

     

    Our Company has historically looked to net income as a performance measure for our executive compensation program. In fiscal 2023, our net income increased $0.9 million, or 20%, as compared to fiscal 2022, and the compensation actually paid for our PEO and non-PEO NEOs also increased between 2022 and 2023.

     

    Compensation Actually Paid and Cumulative TSR 

     

    Historically we have not used financial performance measures such as TSR to align with compensation actually paid to our NEO’s. As described in more detail above, part of the compensation our NEOs are eligible to receive consists of annual performance-based cash bonuses and equity awards that are designed to provide appropriate incentives to our executives to achieve defined annual corporate goals.

     

    All information provided above under the “Pay Versus Performance” heading will not be deemed to be incorporated by reference in any filing of our Company under the Securities Act of 1933, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.

     

     

     

     

     

    NON-EXECUTIVE DIRECTOR COMPENSATION

     

    We currently have five directors, four of whom are considered independent. Non-independent directors who are also employees of the Company do not receive compensation for their services as a director on the Board. Prior to November 8, 2023, each of our non-employee directors were entitled to receive $40,000 per annum for their services on the Board pursuant to the Company’s current director compensation plan, which compensation may be paid in cash, shares of Company Common Stock or a combination thereof, at the option of each individual director. Effective November 8, 2023, the compensation paid to our non-employee directors increased to $50,000 per annum.

     

    The table below summarizes the compensation paid to our non-employee directors for the fiscal year ended December 31, 2023:

     

       

    Fees earned
    or paid in
    cash

       

    Stock
    awards

       

    Option
    awards

       

    Total

     
                                     

    Grant Dawson

      $ 42,500     $ -     $ -     $ 42,500  

    Lewis Jaffe

      $ 42,500     $ -     $ -     $ 42,500  

    Todd Ordal

      $ 42,500     $ -     $ -     $ 42,500  

    Seth Yakatan

      $ 42,500     $ -     $ -     $ 42,500  

     

    Section 16(A) Beneficial Ownership Reporting Compliance

     

    Section 16(a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), requires the Company’s directors and executive officers, and persons who beneficially own more than 10% of a registered class of the Company’s equity securities, to file reports of beneficial ownership and changes in beneficial ownership of the Company’s securities with the SEC on Forms 3 (Initial Statement of Beneficial Ownership), 4 (Statement of Changes of Beneficial Ownership of Securities) and 5 (Annual Statement of Beneficial Ownership of Securities).  Directors, executive officers and beneficial owners of more than 10% of the Company’s Common Stock are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms that they file.

     

    To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended December 31, 2023, management believes that all necessary reports were filed in a timely manner and all filings are current as of the date of this filing.

     

    Code of Business Conduct and Ethics

     

    We have adopted a Code of Business Conduct and Ethics that applies to all of our executive officers, directors and employees, which sets forth the business and ethical principles that govern all aspects of our business. This document will be made available in print, free of charge, to any stockholder requesting a copy in writing from the Company. A form of the Code of Business Conduct and Ethics is filed with the SEC as Exhibit 14.1 to Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

     

    Indemnification of Officers and Directors

     

    As permitted by Nevada law, the Company will indemnify its directors and officers against expense and liabilities they incur to defend, settle, or satisfy any civil or criminal action brought against them on account of their being or having been Company directors or officers unless, in any such action, they are adjudged to have acted with gross negligence or willful misconduct.

     

    Exclusion of Liability

     

    The Nevada Business Corporation Act excludes personal liability for directors for monetary damages based upon any violation of their fiduciary duties as directors, except as to liability for any breach of the duty of loyalty, acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, acts in violation of the Nevada Business Corporation Act, or any transaction from which a director receives an improper personal benefit. This exclusion of liability does not limit any right that a director may have to be indemnified and does not affect any director's liability under federal or applicable state securities laws. 

     

     

     

     

    CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS

     

    There were no transactions between the Company and any of its directors, executive officers or any other related persons during the year ended December 31, 2023.

     

    SECURITY OWNERSHIP OF PRINCIPAL STOCKHOLDERS AND MANAGEMENT

    AND RELATED STOCKHOLDER MATTERS

     

    The following tables set forth information regarding shares of our Common Stock beneficially owned as of July 1, 2024, by:  

     

     

    (i)

    each of our officers and directors;

     

     

    (ii)

    all officers and directors as a group; and

     

     

    (iii)

    each person known by us to beneficially own five percent or more of the outstanding shares of our Common Stock. Percent ownership is calculated based on 4,598,241 shares of our Common Stock outstanding at July 1, 2024.

     

    Beneficial Ownership of our Common Stock

     

    Name and address of owner (1)

    Title of class

     

    Number of

    shares

    owned

       

    Percentage

    of class

     
                       

    Dayton Judd, Chair and Chief Executive Officer (2)

    Common Stock

       

    2,915,529

         

    58.9

    %

                       

    Jakob York, Chief Financial Officer (3)

    Common Stock

       

    11,984

         

    *

     
                       

    Patrick Ryan, Chief Retail Officer

    Common Stock

       

    -

         

    *

     
                       

    Jenna Sinnett, Chief Operating Officer

    Common Stock

       

    5,600

         

    *

     
                       

    Grant Dawson

    Common Stock

       

    76,428

         

    1.7

    %

                       

    Lewis Jaffe

    Common Stock

       

    -

         

    *

     
                       

    Todd Ordal

    Common Stock

       

    30,944

         

    *

     
                       

    Seth Yakatan

    Common Stock

       

    -

         

    *

     
                       

    All Officers and Directors as a group (seven persons)

    Common Stock

       

    3,040,485

         

    61.3

    %

     

    * Less than 1%

     

    (1)

    The address of each of the officers and directors is c/o FitLife Brands, Inc., 5214 S. 136th Street, Omaha, NE 68137.

     

     

    (2)

    Consists of 498,001 shares of Common Stock held by Mr. Judd personally, including shares in IRA accounts; 221,400 shares of Common Stock issuable upon the exercise of stock options at $0.70 per share, exercisable within 60 days of July 1, 2024; 72,000 shares of Common Stock issuable upon the exercise of stock options at $5.24 per share, exercisable within 60 days of July 1, 2024; 56,000 shares of Common Stock issuable upon the exercise of stock options at $4.76 per share, exercisable within 60 days of July 1, 2024; and 2,068,128 shares of Common Stock held by Sudbury Holdings, LLC.

     

     

    (3)

    Consists of 3,484 shares of Common Stock held by Mr. York in IRA accounts, 7,500 shares of Common Stock issuable upon the exercise of stock options at $15.65 per share exercisable within 60 days of July 1, 2024, and 1,000 shares of Common Stock issuable upon the exercise of stock options at $18.15 per share exercisable within 60 days of July 1, 2024.

     

    Changes in Control

     

    The Company is not aware of any arrangements that may result in a change in control of the Company.

     

     

     

     

    REPORT OF THE AUDIT COMMITTEE OF THE BOARD

     

    The Audit Committee oversees the Company’s financial reporting process on behalf of the Board and is responsible for providing independent, objective oversight of the Company’s accounting functions and internal controls. It is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company’s financial statements are complete and accurate and are in accordance with generally accepted accounting principles. Management is responsible for the Company’s financial statements and the reporting process, including the system of internal controls. The independent registered certified public accountants are responsible in their report for expressing an opinion on the conformity of those financial statements with generally accepted accounting principles.

     

    The Audit Committee has reviewed and discussed the Company’s audited financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 with the Company’s management and its independent registered certified public accountants. The Audit Committee met privately with the independent registered certified public accountants and discussed issues deemed significant by the independent registered certified public accountants, including those matters required by Statement on Auditing Standards No. 61 (Codification of Statements on Auditing Standards). In addition, the Audit Committee has received the written disclosures from the independent registered certified public accountants required by the applicable requirements of the Public Company Accounting Oversight Board and discussed with the independent registered certified public accountants their independence from the Company.

     

    Based upon the reviews and discussions outlined above, the Audit Committee recommended to the Board that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, for filing with the SEC.

     

    Audit Committee

     

    Grant Dawson (Chairman)

    Lewis Jaffe

    Todd Ordal

    Seth Yakatan

     

     

    ADDITIONAL INFORMATION

     

    Deadline for Receipt of Stockholder Proposals

     

    Pursuant to Rule 14a-8 under the Exchange Act, stockholder proposals to be presented at our 2025 Annual Meeting of Stockholders and included in our Proxy Statement and form of proxy relating to that annual meeting must be received by us at our principal executive offices at 5214 S. 136th Street, Omaha, Nebraska 68137, addressed to our Corporate Secretary, not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year's annual meeting and must contain specific information concerning the matter to be brought before such meeting and concerning the stockholder proposing such matter. These proposals must comply with applicable Nevada law, the rules and regulations promulgated by the SEC and the procedures set forth in our Bylaws.

     

    We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these and all other applicable requirements.

     

    Householding of Proxy Materials

     

    The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement and annual report addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.

     

     

     

     

    A number of brokers with account holders who are stockholders of the Company will be “householding” the Company’s proxy materials. A single set of the Company’s proxy materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be “householding” communications to your address, “householding” will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in “householding” and would prefer to receive a separate set of the Company’s proxy materials, please notify your broker or direct a written request to the Corporate Secretary at 5214 S. 136th Street, Omaha, Nebraska 68137, or by calling (402) 991-5618. The Company undertakes to deliver promptly, upon any such oral or written request, a separate copy of its proxy materials to a stockholder at a shared address to which a single copy of these documents was delivered. Stockholders who currently receive multiple copies of the Company’s proxy materials at their address and would like to request “householding” of their communications should contact their broker, bank or other nominee, or contact the Company at the above address or phone number. 

     

    Other Matters

     

    At the date of this Proxy Statement, the Company knows of no other matters, other than those described above, that will be presented for consideration at the Annual Meeting. If any other business should come before the Annual Meeting, it is intended that the proxy holders will vote all proxies using their best judgment in the interest of the Company and the stockholders.

     

    The Board of Directors invites you to attend the Annual Meeting in person. Whether or not you expect to attend the Annual Meeting in person, please submit your vote by Internet, telephone or mail as promptly as possible so that your shares will be represented at the Annual Meeting.

     

    REGARDLESS OF WHETHER YOU PLAN TO ATTEND THE ANNUAL MEETING IN PERSON, PLEASE READ THE ACCOMPANYING PROXY STATEMENT AND THEN VOTE BY INTERNET, TELEPHONE OR MAIL AS PROMPTLY AS POSSIBLE.  VOTING PROMPTLY WILL SAVE US ADDITIONAL EXPENSE IN SOLICITING PROXIES AND WILL ENSURE THAT YOUR SHARES ARE REPRESENTED AT THE ANNUAL MEETING.

     

    By order of the Board of Directors,

     

    djudd.jpg

    Dayton Judd

    Chief Executive Officer and Chairman

     

     

     

     

    p02.jpg

     

     
    Get the next $FTLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:01:06 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    SEC Filings

    View All

    FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    12/10/25 8:02:12 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    11/13/25 7:45:16 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by FitLife Brands Inc.

    10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

    11/13/25 7:30:53 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FitLife Brands Announces Third Quarter 2025 Results

    OMAHA, NE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2025. Highlights for the third quarter ended September 30, 2025 include: On August 8, 2025, the Company completed the acquisition of substantially all of the assets of Irwin Naturals ("Irwin"), and Irwin's operating results for the period of August 9 through September 30 are included in FitLife's consolidated financials for the third quarter of 2025.Total revenue was $23.5 million, an increase of 47% compared to the th

    11/13/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Third Quarter Earnings Call

    OMAHA, NE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the third quarter of fiscal 2025 on Thursday, November 13, 2025. In addition, the Company announced that it will hold an investor conference call after market close on November 13, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 811541.  International participants can dial (973) 528-0163 and provide the same co

    11/7/25 4:00:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Second Quarter 2025 Results

    OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1 million, 5% lower than the second quarter of 2024.  Online revenue was $10.4 million, representing 65% of total revenue and down 7% compared to the second quarter of 2024.Gross margin was 42.8% compared to 44.8% during the second quarter of 2024.Net income for the second quarter of 2025 was $1.7 million compared to $2.6 million dur

    8/14/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER York Jakob

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    9/8/25 10:19:11 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:27:11 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Pappas Shannon K.

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:26:27 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on FitLife Brands with a new price target

    Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

    3/17/25 8:22:47 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    ROTH MKM initiated coverage on FitLife Brands with a new price target

    ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

    9/3/24 7:48:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Financials

    Live finance-specific insights

    View All

    FitLife Brands Announces Third Quarter 2025 Results

    OMAHA, NE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2025. Highlights for the third quarter ended September 30, 2025 include: On August 8, 2025, the Company completed the acquisition of substantially all of the assets of Irwin Naturals ("Irwin"), and Irwin's operating results for the period of August 9 through September 30 are included in FitLife's consolidated financials for the third quarter of 2025.Total revenue was $23.5 million, an increase of 47% compared to the th

    11/13/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Third Quarter Earnings Call

    OMAHA, NE, Nov. 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the third quarter of fiscal 2025 on Thursday, November 13, 2025. In addition, the Company announced that it will hold an investor conference call after market close on November 13, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 811541.  International participants can dial (973) 528-0163 and provide the same co

    11/7/25 4:00:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Second Quarter 2025 Results

    OMAHA, NE, Aug. 14, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2025. Highlights for the second quarter ended June 30, 2025 include: Total revenue was $16.1 million, 5% lower than the second quarter of 2024.  Online revenue was $10.4 million, representing 65% of total revenue and down 7% compared to the second quarter of 2024.Gross margin was 42.8% compared to 44.8% during the second quarter of 2024.Net income for the second quarter of 2025 was $1.7 million compared to $2.6 million dur

    8/14/25 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Leadership Updates

    Live Leadership Updates

    View All

    FitLife Brands Announces Board Transition

    Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

    4/28/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    LifeVantage Appoints Dayton Judd to the Board of Directors

    SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

    2/15/24 4:05:00 PM ET
    $FTLF
    $LFVN
    $OPXS
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Electronic Components